Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial (2019)

First Author: Thomas M

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-023765

PubMed Identifier: 30772849

Publication URI: http://europepmc.org/abstract/MED/30772849

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 2

ISSN: 2044-6055